Cantitate/Preț
Produs

Helicobacter pylori

Editat de Nayoung Kim
en Limba Engleză Paperback – 9 dec 2018
This book presents thecurrent state of knowledge regarding the ability of Helicobacter pylori to colonize the gastrointestinal tract, theglobal epidemiology of H. pyloriinfection, transmission routes, the pathophysiology of H. pylori-related gastroduodenal and other diseases, diagnosis andtreatment methods, guidelines for eradication, antibiotic resistance, thereinfection rate after H. pylori eradication,and animal models of H. pylori orrelated Helicobacter infection. Theaim is to equip readers around the world with the understanding required inorder to implement effective methods of H.pylori eradication and to enhance clinical outcomes for patients. The textis clearly written and is complemented by many helpful illustrations. This bookwill be a great asset in clinical practice for all practitioners who areinvolved in caring for patients with H.pylori-related diseases or have an interest in the subject. It will also bea useful source of information for medical students and for intelligent laypeopleseeking information on H. pylori.
Citește tot Restrânge

Toate formatele și edițiile

Toate formatele și edițiile Preț Express
Paperback (1) 102714 lei  38-44 zile
  Springer Nature Singapore – 9 dec 2018 102714 lei  38-44 zile
Hardback (2) 146689 lei  38-44 zile
  Springer Nature Singapore – mar 2024 161900 lei  3-5 săpt.
  Springer Nature Singapore – 27 oct 2016 146689 lei  38-44 zile

Preț: 102714 lei

Preț vechi: 108121 lei
-5% Nou

Puncte Express: 1541

Preț estimativ în valută:
19657 20419$ 16328£

Carte tipărită la comandă

Livrare economică 28 ianuarie-03 februarie 25

Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9789811357060
ISBN-10: 9811357064
Pagini: 556
Ilustrații: X, 556 p. 114 illus., 103 illus. in color.
Dimensiuni: 178 x 254 mm
Ediția:2016
Editura: Springer Nature Singapore
Colecția Springer
Locul publicării:Singapore, Singapore

Cuprins

Part 1. Epidemiology-Prevalence andTransmission routes of H. pylori.- Part 2. Pathophysiology.- 1) Colonization ofH. pylori in the stomach.- 2) Brief description of Pathophysiology.- 3) Immunemechanism.- 4) Change of acid secretion, ghrelin and leptin by H. pylori.- 5) H.pylori virulence factors.- A: toxin (CagA, VacA, DupA, OipA, IceA).- B: geneticpolymorphism of toxin and disease.- 6) Host factors: genetic polymorphism,etc.- Part 3. Diagnosis.- 1) Serology.- 2) Histology.- 3) Culture.- 4) UBT.- 5)Stool antigen.- 6) Specific conditions.- A: Children.- B: Bleeding.- Part4. Symptom.- 1)Symptom of acute and chronic H. pylori infection.- Part 5.Disease.- 1) Atrophic gastritis and Intestinal metaplasia.- 2) Functional dyspepsia.-3) Peptic ulcer.- 4) MALToma.- 5) Gastric cancer.- A: Synopsis and Epidemiologyof gastric cancer.- B1: Pathogenesis: i.Genetic alternation (mutations intumor-related genes) induced by Activation-induced cytidine deaminase (AID).- B2:Pathogenesis: ii. Epigenetic mechanisms: aberrant DNA methylation, microRNA.- B3:Pathogenesis:iii. Macrophage inhibitory factor (MIF).- B4: Pathogenesis: iv.Epidermal mesenchyme transition (EMT).- B5: Pathogenesis: v. ABO blood type.- B6:Pathogenesis: vi. First relatives of gastric cancer.- C: H. pylori-negativegastric cancer.- 6) Gastroesophageal reflux disease (GERD).- 7) NSAID-inducedgastropathy and H. pylori infection.- 8) Extraintestinal manifestations of H.pylori infection.- A: Iron deficiency anemia.- B: Idiopathic thrombocytopenicpurpura.- C: Heart disease.- D: Atopy and allergy.- Part 6. Antibioticresistance.- 1) Synopsis of antibiotic resistance.- 2) Clarithromycin.- 3)Amoxicillin.- 4) Quinolone.- 5) Metronidazole.- Part 7. Treatment.- 1) Synopsisof antibiotic treatment.- 2) Triple therapy.- 3) Quadruple therapy.- 4)Sequential therapy.- 5) Concomitant therapy.- 6) Tailored therapy based onantibiotic resistance.- 7) Levofloxacin or rifabutin based triple therapy.- 8)Probiotics.- 9) Treatment guidelines.- 10) Screening method of early gastriccancer.- 11) Recrudescence and reinfection.- Part 8. Consequences of H.pylori eradication.- 1) Peptic ulcer disease.- 2) atrophic gastritis andIntestinal metaplasia.- 3) Gastric cancer.- Part 9. The effect of H. pylori onthe other microbiota of stomach.- The effect of H. pylori on the othermicrobiota of stomach.- Part 10. Animal model- H. pylori, H. felis.

Notă biografică

Nayoung Kim MD Ph.D., Department of Internal Medicine, Seoul National University College of Medicine, Seoul National University Bundang Hospital, Republic of Korea

Textul de pe ultima copertă

This book presents thecurrent state of knowledge regarding the ability of Helicobacter pylori to colonize the gastrointestinal tract, theglobal epidemiology of H. pyloriinfection, transmission routes, the pathophysiology of H. pylori-related gastroduodenal and other diseases, diagnosis andtreatment methods, guidelines for eradication, antibiotic resistance, thereinfection rate after H. pylori eradication,and animal models of H. pylori orrelated Helicobacter infection. Theaim is to equip readers around the world with the understanding required inorder to implement effective methods of H.pylori eradication and to enhance clinical outcomes for patients. The textis clearly written and is complemented by many helpful illustrations. This bookwill be a great asset in clinical practice for all practitioners who areinvolved in caring for patients with H.pylori-related diseases or have an interest in the subject. It will also bea useful source of information for medical students and for intelligent laypeopleseeking information on H. pylori.

Caracteristici

Presents the latest knowledge on all aspects of H. pylori infection and its consequences Offers detailed guidance on diagnosis and treatment Covers epidemiology, pathophysiology, antibiotic resistance, and reinfection rates